Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C

BACKGROUND: Nearly 0.5% of Iranians are infected with HCV. Peginterferon-alpha-2a and Peginterferon-alpha-2b are the two available types of interferon for the treatment of hepatitis C. Comparing the results of these two treatments is still a challenge. OBJECTIVES: The aim of this study was to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouresmaeeli, Mahdiyar, Alavian, Seyed Moayed, Keshvari, Maryam, Salimi, Shima, Mehrnoush, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612773/
https://www.ncbi.nlm.nih.gov/pubmed/26504470
http://dx.doi.org/10.5812/hepatmon.30780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612773/
https://www.ncbi.nlm.nih.gov/pubmed/26504470
http://dx.doi.org/10.5812/hepatmon.30780

Ejemplares similares